At a glance
Years of experience
0
Annual biopsies
0
Dedicated employees
0
Behind every trial working toward better outcomes for kidney disease, precise pathology matters. That’s where we come in.
Our GCLP and GCP-trained staff, CAP, CLIA, HITRUST (e1), and New York State CLEP-certified laboratories, and advanced core research facilities enable us to partner with academic, pharmaceutical, and biotechnology institutions at all stages of research and development – from initial proof of concept through delivery of results.
Arkana Laboratories serves as a central biopsy processing lab for clinical trials, receiving more than 30,000 biopsies annually. Our team of 240+ employees is committed to the highest quality of clinicopathologic care, bringing unmatched concentration of renal pathology expertise to every study we support.
We partner with academic, pharmaceutical, and biotechnology institutions at every stage of R&D, and we do it through our FDA and GDPR-compliant CRO infrastructure with the security, discretion, and scientific rigor your program demands.
What Our Clinical Trials Division Offers
Our Clinical Trial Services
Arkana’s clinical trials division offers a comprehensive suite of services spanning pre-clinical trial and clinical trial phases. Below is an overview of our current service offerings by category.
| Research Use | Clinical Use | |
|---|---|---|
| Board-Certified Pathologist Reads | ||
| Novel Biomarker Identification | ||
| Stains (Histochemical, Immunohistochemical, Enzymatic) | ||
| Transmission Electron Microscopy | ||
| qPCR (SNP, Copy Number, and Gene Expression) | ||
| NanoString Assays | ||
| APOL1 Genotyping | ||
| RNA/DNA Extraction (FFPE, Cells, Frozen Tissue) | ||
| Whole Slide Scanning | ||
| AI-based Quantitative Image Analysis | ||
| Multiplex Immunofluorescence Microscopy | ||
| Confocal Microscopy | ||
| Histopathologic Processing and Scoring of Tissue Sections | ||
| Biomarker Expression Analysis | ||
| Laser Capture Microdissection to Isolate Tissue Compartments | ||
| Investigation of Therapeutic Target Selection | ||
| Physician Clinical Trial Referral Services | ||
| Mass Spectrometry |
